Event Panel Schedule


TBA
Re­cap of 2020 & The dif­fer­ent IPO mod­els – What have we learned? What worked? What is here to stay? What do we miss the most?
Webcast
1f8d8791b7700138b169a8ee5ca67037_e5a5359fc101696c740bf17f822fe06a_120_120
Oppenheimer & Co. Inc.
Stefan Loren, Ph.D., Managing Director / Oppenheimer & Co. Inc.
Loren is a managing director at Oppenheimer & Co.. Prior to joining Oppenheimer Loren was managing partner at Leap Day Capital (2014-2017) and board director for GenVec (2013-2017). Loren graduated with a PhD. in Organic/Pharmaceutical…

5c9aba5eb693d880d7f36778e6bc76f2_fa1f0401e8c4436557199bd331ea4c70_120_120
Oppenheimer & Co. Inc.
Michael A. Margolis, R.Ph., Co-Head of Healthcare Investment Banking / Oppenheimer & Co. Inc.
Mr. Michael Margolis serves as Co-Head of Healthcare Investment Banking at Oppenheimer & Company. He served as a Managing Director, Healthcare Investment Banking at Roth Capital Partners. He was most recently a Managing Director of Healthcare…

7da8069c29b3bc886949c161dbe5ddf5_21f00029268f57dd1e68fb316c51230b_120_120
Alpha Healthcare Acquisition
Rajiv Shukla, Chairman & CEO / Alpha Healthcare Acquisition
Alpha Healthcare Acquisition Corp is led by Chairman and CEO, Rajiv Shukla. Rajiv is a long-time healthcare investor and 3-time public company CEO. His previous SPAC acquired DermTech, a disruptive non-invasive cancer diagnostic company. DMTK stock…

7c3f6234d9b23670c407c7c66e73afc0_60319bc4b482aad387933bae74451dae_120_120
Larimar Therapeutics
Michael Celano, CFO / Larimar Therapeutics
Michael Celano joined Larimar Therapeutics in June 2020, as Chief Financial Officer (CFO). He brings over 30 years’ experience as a life science business leader with a broad skill set including capital raising, creative financing structures, investor…

30c985430771504df3d516f9e124ad27_4af68c40f253d02c718865724d69e80f_120_120
Solebury Strategic Communications
Jennifer Porcelli, Managing Director / Solebury Trout
Jen Porcelli is a Managing Director in the New York office. Jen works with a broad spectrum of privately-held and publicly-traded life sciences companies throughout various stages of the funding lifecycle; she provides management teams with…

9ce310a9525153aa70b8db06baf7d699_25afa9b87c480e4fe2b96f5c86d9a99f_120_120
White & Case LLP
Joel Rubinstein, Partner / White & Case LLP
Joel Rubinstein is a partner at White & Case, and a member of the Firm’s Capital Markets Practice. Joel has broad experience in corporate and securities matters, representing clients in public offerings and private placements of securities…

F21096076b62f73f829ae18391551c8d_653b69db3c57cc39ed8c21ae2ece650d_120_120
White & Case LLP
Stuart Bressman, Partner / White & Case LLP
Stuart advises investment banks and issuers on public and private securities offerings by US and non-US companies. Clients also seek him out for his market-leading experience in alternative financing techniques, such as confidentially marketed public…
Export to Excel